AmeriServ Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $350K | Sell |
6,035
-440
| -7% | -$27K | 0.65% | 29 |
|
|
2023
Q2 | $414K | Sell |
6,475
-4,365
| -40% | -$293K | 0.78% | 26 |
|
|
2023
Q1 | $751K | Sell |
10,840
-75
| -0.7% | -$5.29K | 1.73% | 14 |
|
|
2022
Q4 | $785K | Sell |
10,915
-35
| -0.3% | -$2.64K | 1.57% | 19 |
|
|
2022
Q3 | $778K | Sell |
10,950
-26
| -0.2% | -$1.89K | 1.71% | 17 |
|
|
2022
Q2 | $845K | Sell |
10,976
-1,283
| -10% | -$97.7K | 1.99% | 16 |
|
|
2022
Q1 | $895K | Buy |
12,259
+1,014
| +9% | +$68.1K | 0.65% | 27 |
|
|
2021
Q4 | $701K | Sell |
11,245
-1,088
| -9% | -$63.8K | 0.48% | 34 |
|
|
2021
Q3 | $730K | Sell |
12,333
-440
| -3% | -$29K | 0.56% | 33 |
|
|
2021
Q2 | $853K | Sell |
12,773
-1,799
| -12% | -$117K | 0.66% | 33 |
|
|
2021
Q1 | $920K | Sell |
14,572
-1,904
| -12% | -$118K | 0.79% | 27 |
|
|
2020
Q4 | $1.02M | Buy |
+16,476
| New | +$1.01M | 1% | 23 |
|
|
2019
Q3 | $774K | Buy |
15,270
+100
| +0.7% | +$4.7K | 1.05% | 21 |
|
|
2019
Q2 | $688K | Buy |
15,170
+869
| +6% | +$40.5K | 0.9% | 27 |
|
|
2019
Q1 | $682K | Sell |
14,301
-305
| -2% | -$15.2K | 1.42% | 24 |
|
|
2018
Q4 | $759K | Buy |
14,606
+169
| +1% | +$9.08K | 1.92% | 18 |
|
|
2018
Q3 | $897K | Sell |
14,437
-504
| -3% | -$29.9K | 1.12% | 19 |
|
|
2018
Q2 | $827K | Sell |
14,941
-665
| -4% | -$35.9K | 1.11% | 21 |
|
|
2018
Q1 | $984K | Buy |
15,606
+245
| +2% | +$15.8K | 1.11% | 20 |
|
|
2017
Q4 | $971K | Buy |
+15,361
| New | +$961K | 0.94% | 20 |
|
|
2017
Q1 | $845K | Buy |
15,530
+388
| +3% | +$21.3K | 1.11% | 19 |
|
|
2016
Q4 | $883K | Buy |
15,142
+4,658
| +44% | +$255K | 1.03% | 19 |
|
|
2016
Q3 | $565K | Sell |
10,484
-1,900
| -15% | -$122K | 0.72% | 33 |
|
|
2016
Q2 | $911K | Sell |
12,384
-375
| -3% | -$26.5K | 1.35% | 16 |
|
|
2016
Q1 | $814K | Sell |
12,759
-1,448
| -10% | -$91.3K | 1.38% | 17 |
|
|
2015
Q4 | $976K | Buy |
14,207
+104
| +0.7% | +$6.87K | 2.31% | 13 |
|
|
2015
Q3 | $835K | Sell |
14,103
-1,334
| -9% | -$84.6K | 1.59% | 18 |
|
|
2015
Q2 | $1.03M | Buy |
15,437
+24
| +0.2% | +$1.58K | 1.19% | 16 |
|
|
2015
Q1 | $994K | Sell |
15,413
-4,583
| -23% | -$287K | 1.15% | 18 |
|
|
2014
Q4 | $1.18M | Buy |
19,996
+449
| +2% | +$25.3K | 1.14% | 12 |
|
|
2014
Q3 | $1M | Sell |
19,547
-1,191
| -6% | -$59.5K | 1.73% | 9 |
|
|
2014
Q2 | $1.01M | Sell |
20,738
-2,293
| -10% | -$113K | 1.08% | 15 |
|
|
2014
Q1 | $1.2M | Sell |
23,031
-16,415
| -42% | -$873K | 1.2% | 12 |
|
|
2013
Q4 | $2.1M | Sell |
39,446
-276
| -0.7% | -$14.1K | 1.25% | 16 |
|
|
2013
Q3 | $1.84M | Buy |
39,722
+80
| +0.2% | +$3.51K | 1.17% | 18 |
|
|
2013
Q2 | $1.77M | Buy |
+39,642
| New | +$1.72M | 1.14% | 19 |
|
Other funds holding BMY
AmeriServ Wealth Advisors's BMY Position: Q3 2023 in Review
AmeriServ Wealth Advisors reduced its Bristol-Myers Squibb (BMY) stake by 6.8% in Q3 2023, selling an estimated $27K and leaving 6,035 shares worth $350K. The position accounts for 0.65% of the portfolio, ranked #29.
AmeriServ Wealth Advisors first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.1M in Q4 2013. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- AmeriServ Wealth Advisors held 6,035 shares of Bristol-Myers Squibb worth $350K as of Q3 2023.
- AmeriServ Wealth Advisors sold 440 Bristol-Myers Squibb shares in Q3 2023, an estimated $27K.
- Bristol-Myers Squibb made up 0.65% of AmeriServ Wealth Advisors's portfolio in Q3 2023, its #29 holding.
- AmeriServ Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- AmeriServ Wealth Advisors's Bristol-Myers Squibb position peaked at $2.1M in Q4 2013.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on AmeriServ Wealth Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.